NO20055449D0 - Fremgangsmate for diagnostisering av behandling av kreft - Google Patents

Fremgangsmate for diagnostisering av behandling av kreft

Info

Publication number
NO20055449D0
NO20055449D0 NO20055449A NO20055449A NO20055449D0 NO 20055449 D0 NO20055449 D0 NO 20055449D0 NO 20055449 A NO20055449 A NO 20055449A NO 20055449 A NO20055449 A NO 20055449A NO 20055449 D0 NO20055449 D0 NO 20055449D0
Authority
NO
Norway
Prior art keywords
procedure
cancer treatment
diagnosing cancer
diagnosing
treatment
Prior art date
Application number
NO20055449A
Other languages
English (en)
Other versions
NO20055449L (no
Inventor
Steven C Quay
Kunyuan Cui
Original Assignee
Nastech Pharm Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nastech Pharm Co filed Critical Nastech Pharm Co
Publication of NO20055449D0 publication Critical patent/NO20055449D0/no
Publication of NO20055449L publication Critical patent/NO20055449L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Microbiology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20055449A 2003-04-30 2005-11-17 Fremgangsmate for diagnostisering av behandling av kreft NO20055449L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46690503P 2003-04-30 2003-04-30
PCT/US2004/013436 WO2004098647A2 (en) 2003-04-30 2004-04-30 Claudins’ underexpression as markers of tumor metastasis

Publications (2)

Publication Number Publication Date
NO20055449D0 true NO20055449D0 (no) 2005-11-17
NO20055449L NO20055449L (no) 2006-01-26

Family

ID=33434995

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20055449A NO20055449L (no) 2003-04-30 2005-11-17 Fremgangsmate for diagnostisering av behandling av kreft

Country Status (8)

Country Link
US (1) US20040253211A1 (no)
EP (1) EP1620732A2 (no)
JP (1) JP2006525351A (no)
CN (1) CN100575955C (no)
CA (1) CA2523870A1 (no)
MX (1) MXPA05011644A (no)
NO (1) NO20055449L (no)
WO (1) WO2004098647A2 (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2568899T3 (es) 1999-04-09 2016-05-05 Kyowa Hakko Kirin Co., Ltd. Procedimiento para controlar la actividad de una molécula inmunofuncional
US6946292B2 (en) 2000-10-06 2005-09-20 Kyowa Hakko Kogyo Co., Ltd. Cells producing antibody compositions with increased antibody dependent cytotoxic activity
WO2008072723A1 (ja) * 2006-12-14 2008-06-19 Forerunner Pharma Research Co., Ltd. 抗Claudin3モノクローナル抗体およびそれを用いる癌の治療および診断
JPWO2008114733A1 (ja) 2007-03-16 2010-07-01 協和発酵キリン株式会社 抗Ｃｌａｕｄｉｎ−４抗体
EP2404936A1 (en) * 2010-07-06 2012-01-11 Ganymed Pharmaceuticals AG Cancer therapy using CLDN6 target-directed antibodies in vivo
KR101741898B1 (ko) 2015-05-27 2017-06-01 울산대학교 산학협력단 Claudin 7을 포함하는 방사선 반응성 위암 진단용 바이오마커 조성물

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5554388A (en) * 1989-02-25 1996-09-10 Danbiosyst Uk Limited Systemic drug delivery compositions comprising a polycationi substance
US5744166A (en) * 1989-02-25 1998-04-28 Danbiosyst Uk Limited Drug delivery compositions
GB9202464D0 (en) * 1992-02-05 1992-03-18 Danbiosyst Uk Composition for nasal administration
GB9310412D0 (en) * 1993-05-20 1993-07-07 Danbiosyst Uk Nasal nicotine system
GB9412394D0 (en) * 1994-06-21 1994-08-10 Danbiosyst Uk Colonic drug delivery composition
GB9419979D0 (en) * 1994-10-04 1994-11-16 Medeva Holdings Bv Vaccine compositions
GB9522351D0 (en) * 1995-11-01 1996-01-03 Medeva Holdings Bv Vaccine compositions
GB9525083D0 (en) * 1995-12-07 1996-02-07 Danbiosyst Uk Vaccine compositions
US5976800A (en) * 1996-06-28 1999-11-02 The Regents Of The University Of California Enhancement of cancer cell death
NZ504786A (en) * 1997-12-02 2005-07-29 West Pharm Serv Drug Res Ltd Sustained release compositions for nasal administration of drugs for treating erectile disfunction and parkinson's disease
GB9726916D0 (en) * 1997-12-19 1998-02-18 Danbiosyst Uk Nasal formulation
US6248864B1 (en) * 1997-12-31 2001-06-19 Adherex Technologies, Inc. Compounds and methods and modulating tissue permeability
AU2001253140A1 (en) * 2000-04-03 2001-10-15 The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services Tumor markers in ovarian cancer
WO2003069307A2 (en) * 2002-02-14 2003-08-21 The Johns Hopkins University School Of Medicine Claudins, markers for diagnosis, prognosis and therapy of breast, bone, brain cancer

Also Published As

Publication number Publication date
JP2006525351A (ja) 2006-11-09
CN100575955C (zh) 2009-12-30
US20040253211A1 (en) 2004-12-16
WO2004098647A3 (en) 2005-03-03
NO20055449L (no) 2006-01-26
MXPA05011644A (es) 2005-12-15
WO2004098647A2 (en) 2004-11-18
EP1620732A2 (en) 2006-02-01
CN1816745A (zh) 2006-08-09
CA2523870A1 (en) 2004-11-18

Similar Documents

Publication Publication Date Title
LTPA2019511I1 (lt) Rapamicino darinys, skirtas plaučių vėžio gydymui
IS8125A (is) Kínasólínafleiður til að meðhöndla krabbamein
NO20035156D0 (no) Fremgangsmåter for brönnbehandling
IS7670A (is) Samsett meðferð fyrir offjölgunar sjúkdóma
IS8398A (is) Lyfjasamsetningar til að meðhöndla æxli
DE602004019373D1 (de) Bilderzeugungsverfahren
DE602004026245D1 (de) Endoskop
IS7691A (is) Lyfjasamsetningar til að meðhöndla æxli
DE602004021746D1 (de) Endoskop
NO20053782D0 (no) Behandling av kreft med 2-deoksyglukose
NO20034321D0 (no) Fremgangsmåte for identifisering
DE60316652D1 (de) Endoskop
ATE512965T1 (de) Pyrrolopyrimidin derivate
NO20070251A (no) Brønnbehandling
NO20070297A (no) Brønnbehandling
DK1660041T3 (da) Ikke-polær fotosensibilisator til fotodynamisk terapi
IS6917A (is) Epóþílon afleiður til meðhöndlunar erfiðra æxla
NO20040516L (no) Kombinasjonsterapi for behandling av kreft.
DK1499730T3 (da) Immunokonjugater til behandling af tumorer
DE602004012562D1 (de) Strahlaufbereitungssystem
NO20045554L (no) Fremgangsmate for behandling av diabetes
NO20055449D0 (no) Fremgangsmate for diagnostisering av behandling av kreft
NO20063114L (no) Enoxaparin for behandling av cancer
NO20054034D0 (no) Fremgangsmate for behandling av hypotyroidisme.
DE10347306B4 (de) Schirmanbindung

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application